Phase II trial of induction irinotecan-cisplatin followed by concurrent irinotecan-cisplatin and radiotherapy for unresectable, locally advanced gastric and oesophageal-gastric junction adenocarcinoma

1. Rivera, F.
2. Galán, M.
3. Tabernero, J.
4. Cervantes, A.
5. Vega-Villegas, M.E.
6. Gallego, J.
7. Laquente, B.
8. Rodríguez, E.
9. Carrato, A.
10. Escudero, P.
11. Massutí, B.
12. Alonso-Orduña, V.
13. Cardenal, A.
14. Sáenz, A.
15. Giralt, J.
16. Yuste, A.L.
17. Antón, A.
18. Aranda, E.